Incyte Corp (NAS:INCY)
$ 69.91 0.07 (0.1%) Market Cap: 13.47 Bil Enterprise Value: 11.73 Bil PE Ratio: 499.36 PB Ratio: 4.25 GF Score: 89/100

Incyte Corp at Wells Fargo Healthcare Conference Transcript

Sep 07, 2023 / 12:45PM GMT
Release Date Price: $63.45 (+0.41%)
Derek Christian Archila
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

All right. Good morning, everyone. We'll get started with the next fireside discussion. My name is Derek Archila. I'm one of the senior biotech analysts here at Wells. Very excited to have with us for the next discussion, Incyte. From the company, we have the Chairman and CEO, Herve Hoppenot; and also the CFO, Christiana Stamoulis. Thank you so much for joining us.

Herve Hoppenot
Incyte Corporation - CEO & Chairman

Good morning. Thank you for inviting us.

Derek Christian Archila
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

Yes. Well, look forward to the discussion.

Questions & Answers

Derek Christian Archila
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

But maybe, Herve, if you want to just start by kind of giving us kind of a state of the business, where you guys are and what you guys are executing on, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot